Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014
Modern-day stenting procedures leverage advances in pharmacotherapy and device
innovation. Patients treated with contemporary antiplatelet agents, peri-procedural …
innovation. Patients treated with contemporary antiplatelet agents, peri-procedural …
Diabetes and restenosis
Restenosis, defined as the re-narrowing of an arterial lumen after revascularization,
represents an increasingly important issue in clinical practice. Indeed, as the number of stent …
represents an increasingly important issue in clinical practice. Indeed, as the number of stent …
In-stent restenosis in the drug-eluting stent era
The introduction of the drug-eluting stent (DES) proved to be an important step forward in
reducing rates of restenosis and target lesion revascularization after percutaneous coronary …
reducing rates of restenosis and target lesion revascularization after percutaneous coronary …
Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis
T Inoue, K Croce, T Morooka, M Sakuma… - JACC: Cardiovascular …, 2011 - jacc.org
The cellular and molecular processes that control vascular injury responses after
percutaneous coronary intervention involve a complex interplay among vascular cells and …
percutaneous coronary intervention involve a complex interplay among vascular cells and …
Drug-coated balloon angioplasty versus drug-eluting stent implantation in patients with coronary stent restenosis
D Giacoppo, F Alfonso, B Xu, BEPM Claessen… - Journal of the American …, 2020 - jacc.org
Background In patients with coronary in-stent restenosis (ISR) requiring reintervention, it is
unclear if the choice of treatment should depend on whether the restenotic stent was a bare …
unclear if the choice of treatment should depend on whether the restenotic stent was a bare …
Vascular smooth muscle cell proliferation in restenosis
Current therapeutic approaches to restore blood flow in stenotic blood vessels involve the
use of percutaneous devices and coronary bypass surgery. In all procedures that disrupt the …
use of percutaneous devices and coronary bypass surgery. In all procedures that disrupt the …
[HTML][HTML] FGF regulates TGF-β signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression
Maintenance of normal endothelial function is critical to various aspects of blood vessel
function, but its regulation is poorly understood. In this study, we show that disruption of …
function, but its regulation is poorly understood. In this study, we show that disruption of …
Mechanisms of drug-eluting stent restenosis
J Aoki, K Tanabe - Cardiovascular intervention and therapeutics, 2021 - Springer
Drug-eluting stents (DES) were developed to overcome in-stent restenosis (ISR), which has
long been considered the main complication limiting the long-term efficacy of coronary …
long been considered the main complication limiting the long-term efficacy of coronary …
Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors
The aim of this study was to exploit the possibility of combination of active targeting function
of folic acid by folate receptor-mediated endocytosis and overcoming multidrug resistance …
of folic acid by folate receptor-mediated endocytosis and overcoming multidrug resistance …
Drug-coated balloon therapy in coronary and peripheral artery disease
Nonstent-based local drug delivery during percutaneous intervention offers potential for
sustained antirestenotic efficacy without the limitations of permanent vascular implants …
sustained antirestenotic efficacy without the limitations of permanent vascular implants …